Skip to main content

Select Drug Profiles

In the News, FDA Approvals

“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer

The Oncology Drug Pipeline Shows No Evidence of Slowing Down

NIH-Supported Research Outlines the Genetic Architecture of Type 2 Diabetes

CMS’s Andy Slavitt Considers Delaying MACRA Implementation

Improving Population Health by Working with Communities

David B. Nash, MD, MBA

Original Research

Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients

Jordan D. Haag, PharmD, RPh, Amanda Z. Davis, PharmD, RPh, Robert W. Hoel, PharmD, RPh, Jeffrey J. Armon, PharmD, RPh, Laura J. Odell, PharmD, RPh, Ross A. Dierkhising, MS, Paul Y. Takahashi, MD

Stakeholder Perspective

A Systematic Approach to Medication Therapy Management in Elderly Patients with Chronic Diseases Can Improve Outcomes

by James T. Kennedy, Jr, RPh, MBA

Practice Management

Hospital and Health Plan Partnerships: The Affordable Care Act’s Impact on Promoting Health and Wellness

Michelle Vu, PharmD candidate, Annesha White, PharmD, PhD, Virginia P. Kelley, MBA, Jennifer Kuca Hopper, MS, Cathy Liu, PharmD candidate

Stakeholder Perspective

Measurable Clarity in Healthcare Is Needed So Those Who Use the System Could Achieve a State of Well-Being

by F. Randy Vogenberg, PhD, FASHP

Practice Management

Oncologist Support for Consolidated Payments for Cancer Care Management in the United States

Siva Narayanan, MSc, Emily Hautamaki, MPH

Stakeholder Perspective

Implementing Payment Reform in Oncology: Benefits and Challenges

by Byron C. Scott, MD, MBA

FDA Approvals, In the News

Nuplazid First Drug Approved for Hallucinations and Delusions Associated with Parkinson’s Disease

FDA Approvals, In the News

Zynbrita a New Treatment Available for Relapsing Multiple Sclerosis

Page 109 of 244
Results 1081 - 1090 of 2434